PCM
LUNG icon

Prelude Capital Management’s Pulmonx LUNG Stock Holding History

Prelude Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,200
Closed -$103K – 1437
2024
Q2 		$103K Buy
16,200
+4,000
+33% +$30.8K 0.01% 1098
2024
Q1 		$113K Sell
12,200
-712
-6% -$8.35K 0.01% 1188
2023
Q4 		$165K Buy
+12,912
New +$135K 0.01% 984
2022
Q4 		– Sell
-21,704
Closed -$362K – 1491
2022
Q3 		$362K Buy
+21,704
New +$400K 0.01% 788
2022
Q1 		– Sell
-11,300
Closed -$362K – 2056
2021
Q4 		$362K Buy
11,300
+3,205
+40% +$117K 0.01% 1210
2021
Q3 		$291K Buy
8,095
+104
+1% +$4.09K 0.01% 1146
2021
Q2 		$353K Buy
+7,991
New +$348K 0.01% 1130

Other funds holding LUNG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Prelude Capital Management's LUNG Position: Q3 2024 in Review

Prelude Capital Management sold out of Pulmonx (LUNG) in Q3 2024, closing a stake of 16,200 shares — an estimated $103K sold.

Prelude Capital Management first reported a position in LUNG in Q2 2021 and held it in 7 quarters. The position peaked at $362K in Q3 2022. 113 funds tracked by Wall St. Rank hold LUNG as of Q3 2024.

  • Prelude Capital Management reported no remaining Pulmonx position as of Q3 2024 after selling out during the quarter.
  • Prelude Capital Management sold 16,200 Pulmonx shares in Q3 2024, an estimated $103K.
  • Prelude Capital Management first reported a position in Pulmonx in Q2 2021 and held it in 7 quarters.
  • Prelude Capital Management's Pulmonx position peaked at $362K in Q3 2022.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q3 2024.

Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.